世界のてんかん発作治療市場2020年ー2030年:治療薬別(ミダゾラム、アルプラゾラム、ジアゼパム、ロラゼパム、フェニトイン、フォスフェニトイン、その他)、種類別、投与経路別、流通チャネル別

◆英語タイトル:Epileptic Seizures Treatment Market (Therapeutic: Midazolam, Alprazolam, Diazepam, Lorazepam, Phenytoin, Fosphenytoin, and Others; Type: Repetitive Seizures, Status Epilepticus, and Others; Route of Administration: Oral/Buccal, Rectal, Nasal, and Parenteral; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030
◆商品コード:TMR21MC164
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2020年10月30日
◆ページ数:219
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,795 ⇒換算¥660,630見積依頼/購入/質問フォーム
Site Licence(同一拠点内共有可)USD8,795 ⇒換算¥1,002,630見積依頼/購入/質問フォーム
Enterprisewide Licence(複数拠点内共有可)USD11,795 ⇒換算¥1,344,630見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Transparency Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Transparency Market Research社の本調査資料では、世界のてんかん発作治療市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、治療薬別(ミダゾラム、アルプラゾラム、ジアゼパム、ロラゼパム、フェニトイン)分析、種類別分析、投与経路別分析、流通チャネル別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況、キーインサイトなど、以下の構成でまとめております。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・てんかん発作治療の世界市場規模:治療薬別(ミダゾラム、アルプラゾラム、ジアゼパム、ロラゼパム、フェニトイン)
・てんかん発作治療の世界市場規模:種類別
・てんかん発作治療の世界市場規模:投与経路別
・てんかん発作治療の世界市場規模:流通チャネル別
・てんかん発作治療の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況
【レポートの概要】

Epileptic Seizures Treatment Market – Scope of the Report

TMR’s report on the global epileptic seizures treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the overall market revenue of the global epileptic seizures treatment market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global epileptic seizures treatment market for the forecast period.

The report has been prepared after extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global epileptic seizures treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the global epileptic seizures treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global epileptic seizures treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global epileptic seizures treatment market.

The report delves into the competition landscape of the global epileptic seizures treatment market. Key players operating in the global epileptic seizures treatment market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global epileptic seizures treatment market that have been profiled in this report.

Key Questions Answered in Epileptic Seizures Treatment Market Report

What is the sales/revenue generated by each therapeutic, type, route of administration, and distribution channel segment of the global epileptic seizures treatment market across all regions during the forecast period?
What are the opportunities in the global epileptic seizures treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is likely to expand at the fastest CAGR during the forecast period?
Which epileptic seizures treatment segments are expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market share or position of different companies operating in the global market in 2019?
Epileptic Seizures Treatment Market – Research Objectives and Research Approach

The comprehensive report on the global epileptic seizures treatment market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, pipeline analysis, disease prevalence in key countries, key industry events, and impact of COVID-19 in global epileptic seizures treatment market have been provided.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small ones. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global epileptic seizures treatment market in terms of therapeutic, type, route of administration, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global epileptic seizures treatment market.

【レポートの目次】

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Epileptic Seizures Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Epileptic Seizures Treatment Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pipeline Analysis
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Key Industry Events (mergers, acquisitions, collaborations, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Therapeutics
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Therapeutics, 2018–2030
6.3.1. Midazolam
6.3.2. Alprazolam
6.3.3. Diazepam
6.3.4. Lorazepam
6.3.5. Phenytoin
6.3.6. Fosphenytoin
6.3.7. Others
6.4. Market Attractiveness Analysis, by Therapeutics
7. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2018–2030
7.3.1. Repetitive Seizures
7.3.2. Status Epilepticus
7.3.2.1. Convulsive Status Epilepticus
7.3.2.2. Non-convulsive Status Epilepticus
7.3.3. Others
7.4. Market Attractiveness Analysis, by Type
8. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Route of Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Route of Administration, 2018–2030
8.3.1. Oral/Buccal
8.3.2. Rectal
8.3.3. Nasal
8.3.4. Parenteral
8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Distribution Channel, 2018–2030
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Attractiveness Analysis, by Distribution Channel
10. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Epileptic Seizures Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Therapeutics, 2018–2030
11.2.1. Midazolam
11.2.2. Alprazolam
11.2.3. Diazepam
11.2.4. Lorazepam
11.2.5. Phenytoin
11.2.6. Fosphenytoin
11.2.7. Others
11.3. Market Value Forecast, by Type, 2018–2030
11.3.1. Repetitive Seizures
11.3.2. Status Epilepticus
11.3.2.1. Convulsive Status Epilepticus
11.3.2.2. Non-convulsive Status Epilepticus
11.3.3. Others
11.4. Market Value Forecast, by Route of Administration, 2018–2030
11.4.1. Oral/Buccal
11.4.2. Rectal
11.4.3. Nasal
11.4.4. Parenteral
11.5. Market Value Forecast, by Distribution Channel, 2018–2030
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country, 2018–2030
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Therapeutics
11.7.2. By Type
11.7.3. By Route of Administration
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Epileptic Seizures Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Therapeutics, 2018–2030
12.2.1. Midazolam
12.2.2. Alprazolam
12.2.3. Diazepam
12.2.4. Lorazepam
12.2.5. Phenytoin
12.2.6. Fosphenytoin
12.2.7. Others
12.3. Market Value Forecast, by Type, 2018–2030
12.3.1. Repetitive Seizures
12.3.2. Status Epilepticus
12.3.2.1. Convulsive Status Epilepticus
12.3.2.2. Non-convulsive Status Epilepticus
12.3.3. Others
12.4. Market Value Forecast, by Route of Administration, 2018–2030
12.4.1. Oral/Buccal
12.4.2. Rectal
12.4.3. Nasal
12.4.4. Parenteral
12.5. Market Value Forecast, by Distribution Channel, 2018–2030
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Therapeutics
12.7.2. By Type
12.7.3. By Route of Administration
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Epileptic Seizures Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Therapeutics, 2018–2030
13.2.1. Midazolam
13.2.2. Alprazolam
13.2.3. Diazepam
13.2.4. Lorazepam
13.2.5. Phenytoin
13.2.6. Fosphenytoin
13.2.7. Others
13.3. Market Value Forecast, by Type, 2018–2030
13.3.1. Repetitive Seizures
13.3.2. Status Epilepticus
13.3.2.1. Convulsive Status Epilepticus
13.3.2.2. Non-convulsive Status Epilepticus
13.3.3. Others
13.4. Market Value Forecast, by Route of Administration, 2018–2030
13.4.1. Oral/Buccal
13.4.2. Rectal
13.4.3. Nasal
13.4.4. Parenteral
13.5. Market Value Forecast, by Distribution Channel, 2018–2030
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2018–2030
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Therapeutics
13.7.2. By Type
13.7.3. By Route of Administration
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Epileptic Seizures Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Therapeutics, 2018–2030
14.2.1. Midazolam
14.2.2. Alprazolam
14.2.3. Diazepam
14.2.4. Lorazepam
14.2.5. Phenytoin
14.2.6. Fosphenytoin
14.2.7. Others
14.3. Market Value Forecast, by Type, 2018–2030
14.3.1. Repetitive Seizures
14.3.2. Status Epilepticus
14.3.2.1. Convulsive Status Epilepticus
14.3.2.2. Non-convulsive Status Epilepticus
14.3.3. Others
14.4. Market Value Forecast, by Route of Administration, 2018–2030
14.4.1. Oral/Buccal
14.4.2. Rectal
14.4.3. Nasal
14.4.4. Parenteral
14.5. Market Value Forecast, by Distribution Channel, 2018–2030
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2018–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Therapeutics
14.7.2. By Type
14.7.3. By Route of Administration
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Epileptic Seizures Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Therapeutics, 2018–2030
15.2.1. Midazolam
15.2.2. Alprazolam
15.2.3. Diazepam
15.2.4. Lorazepam
15.2.5. Phenytoin
15.2.6. Fosphenytoin
15.2.7. Others
15.3. Market Value Forecast, by Type, 2018–2030
15.3.1. Repetitive Seizures
15.3.2. Status Epilepticus
15.3.2.1. Convulsive Status Epilepticus
15.3.2.2. Non-convulsive Status Epilepticus
15.3.3. Others
15.4. Market Value Forecast, by Route of Administration, 2018–2030
15.4.1. Oral/Buccal
15.4.2. Rectal
15.4.3. Nasal
15.4.4. Parenteral
15.5. Market Value Forecast, by Distribution Channel, 2018–2030
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Pharmacies
15.6. Market Value Forecast, by Country/Sub-region, 2018–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Therapeutics
15.7.2. By Type
15.7.3. By Route of Administration
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share/Position Analysis, by Company, 2019
16.3. Competitive Business Strategies
16.4. Company Profiles
16.4.1. Bausch Health Companies, Inc.
16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.1.2. Company Financials
16.4.1.3. Growth Strategies
16.4.1.4. SWOT Analysis
16.4.2. GlaxoSmithKline plc.
16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.2.2. Company Financials
16.4.2.3. Growth Strategies
16.4.2.4. SWOT Analysis
16.4.3. UCB S.A.
16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.3.2. Company Financials
16.4.3.3. Growth Strategies
16.4.3.4. SWOT Analysis
16.4.4. Pfizer, Inc.
16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.4.2. Company Financials
16.4.4.3. Growth Strategies
16.4.4.4. SWOT Analysis
16.4.5. Apotex, Inc.
16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.5.2. Company Financials
16.4.5.3. Growth Strategies
16.4.5.4. SWOT Analysis
16.4.6. Alexza Pharmaceuticals, Inc.
16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.6.2. Company Financials
16.4.6.3. Growth Strategies
16.4.6.4. SWOT Analysis
16.4.7. Neurelis, Inc.
16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.7.2. Company Financials
16.4.7.3. Growth Strategies
16.4.7.4. SWOT Analysis
16.4.8. Veriton Pharma
16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.8.2. Company Financials
16.4.8.3. Growth Strategies
16.4.8.4. SWOT Analysis

List of Tables

Table 01: Pipeline Analysis

Table 02: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 03: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 04: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 05: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 06: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 07: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 08: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 09: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 10: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 11: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 12: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 13: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 14: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 15: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 16: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 17: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 18: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 19: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 20: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 21: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 22: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 23: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 24: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 25: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 26: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 27: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 28: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 29: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 30: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 31: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 32: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 33: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 34: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 35: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 36: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 37: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

List of Figures

Figure 01: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Epileptic Seizures Treatment Market Value Share, by Therapeutics, 2019

Figure 03: Global Epileptic Seizures Treatment Market Value Share, by Type, 2019

Figure 04: Global Epileptic Seizures Treatment Market Value Share, by Route of Administration 2019

Figure 05: Global Epileptic Seizures Treatment Market Value Share, by Distribution Channel, 2019

Figure 06: Global Epileptic Seizures Treatment Market Value Share, by Region, 2019

Figure 07: Global Epileptic Seizures Treatment Market Value Share, by Status Epilepticus, 2019

Figure 08: Global Epileptic Seizures Treatment Market Value Share Analysis, by Therapeutics, 2019 and 2030

Figure 09: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Midazolam, 2018–2030

Figure 10: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Alprazolam, 2018–2030

Figure 11: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Diazepam, 2018–2030

Figure 12: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Lorazepam, 2018–2030

Figure 13: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Phenytoin, 2018–2030

Figure 14: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Fosphenytoin, 2018–2030

Figure 15: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Others, 2018–2030

Figure 16: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 17: Global Epileptic Seizures Treatment Market Value Share Analysis, by Type, 2019 and 2030

Figure 18: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Repetitive Seizures, 2018-2030

Figure 19: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Status Epilepticus, 2018-2030

Figure 20: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Others, 2018–2030

Figure 21: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 22: Global Epileptic Seizures Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 23: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Oral/Buccal, 2018–2030

Figure 24: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Rectal, 2018–2030

Figure 25: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Nasal, 2018–2030

Figure 26: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Parenteral, 2018–2030

Figure 27: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 28: Global Epileptic Seizures Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 29: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2030

Figure 30: Global Epileptic Seizures Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018-2030

Figure 31: Global Epileptic Seizures Treatment Market Value (US$ Mn), by Online Pharmacies, 2018–2030

Figure 32: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 33: Global Epileptic Seizures Treatment Market Value Share Analysis, by Region, 2019 and 2030

Figure 34: Global Epileptic Seizures Treatment Market Attractiveness Analysis, by Region, 2020–2030

Figure 35: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 36: North America Epileptic Seizures Treatment Market Value Share (%), by Country, 2019 and 2030

Figure 37: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Country, 2020–2030

Figure 38: North America Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030

Figure 39: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 40: North America Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030

Figure 41: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 42: North America Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 43: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 44: North America Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 45: North America Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 46: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 47: Europe Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 48: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 49: Europe Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030

Figure 50: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 51: Europe Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030

Figure 52: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 53: Europe Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 54: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 55: Europe Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 56: Europe Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 57: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 58: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 59: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 60: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030

Figure 61: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 62: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030

Figure 63: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 64: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 65: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 66: Asia Pacific Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 67: Asia Pacific Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 68: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 69: Latin America Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 70: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 71: Latin America Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030

Figure 72: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 73: Latin America Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030

Figure 74: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 75: Latin America Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 76: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 77: Latin America Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 78: Latin America Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 79: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 80: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 81: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 82: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Therapeutics, 2019 and 2030

Figure 83: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Therapeutics, 2020–2030

Figure 84: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Type, 2019 and 2030

Figure 85: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 86: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 87: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 88: Middle East & Africa Epileptic Seizures Treatment Market Value Share (%), by Distribution Channel, 2019 and 2030

Figure 89: Middle East & Africa Epileptic Seizures Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 90: Market Position/Ranking Analysis, 2019, by Tier and Size of the Company

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のてんかん発作治療市場2020年ー2030年:治療薬別(ミダゾラム、アルプラゾラム、ジアゼパム、ロラゼパム、フェニトイン、フォスフェニトイン、その他)、種類別、投与経路別、流通チャネル別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆